DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Heider U, Kaiser M, Muller C. et al.
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment.
Eur J Haematol 2006; 77 (3): 233-238
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.